Please assess the completion status of the following clinical trial:

Trial Title: The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with sepsis or septic shock within the first 24 hours after ICU admission.~Exclusion Criteria:~* Age \< 18 years,~* Pregnancy,~* Advanced malignancy,~* History of kidney stone, glucose-6-phosphate deficiency, hemochromatosis, or solid organ transplantation,~* Oral mucosal inflammation or injury or technical difficulties in obtaining sublingual images.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ascorbic acid (Type: EXPERIMENTAL): Patients received a high dose of intravenous ascorbic acid in four equal parts daily for 96 hours.~Images of sublingual microcirculation were obtained at a baseline, after 0.5, 6, 12, 24, 48, 72, and 96 hours.
- Placebo (Type: PLACEBO_COMPARATOR): Patients received placebo solution matching ascorbic acid solution as four equal parts daily for 96 hours. Images of sublingual microcirculation were obtained at a baseline, after 0.5, 6, 12, 24, 48, 72, and 96 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).